Rare Neurological Diseases in the EU: The Importance of Early Diagnosis and Real World Evidence to Drive Better Patient Outcomes
On 7 December 2022 at 16:00-17:30, the European Alliance for Patient Access (EAfPA), with support of the European Brain Council (EBC) and European Federation of Neurological Associations (EFNA), hosted an event in the European Parliament on Rare Neurological Diseases in the EU, exploring the importance of early diagnosis and real-world evidence (RWE) to drive better [...]